Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   TEVA PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
TEVA PHARMA
Dec-13
PROCTER & GAMBLE HEALTH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5,3663,489-   
Low Rs3,8833,031-   
Sales per share (Unadj.) Rs740.72,002.4-  
Earnings per share (Unadj.) Rs138.2125.1-  
Cash flow per share (Unadj.) Rs155.2286.9-  
Dividends per share (Unadj.) Rs95.00109.50-  
Avg Dividend yield %2.13.4 61.2%  
Book value per share (Unadj.) Rs447.62,224.3-  
Shares outstanding (eoy) m16.60848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.21.6 383.4%   
Avg P/E ratio x33.526.1 128.4%  
P/CF ratio (eoy) x29.811.4 262.3%  
Price / Book Value ratio x10.31.5 704.8%  
Dividend payout %68.787.5 78.5%   
Avg Mkt Cap Rs m76,7612,764,488 2.8%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,0620-   
Avg. sales/employee Rs Th037,780.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,360.1-  
INCOME DATA
Net Sales Rs m12,2961,698,047 0.7%  
Other income Rs m1840-   
Total revenues Rs m12,4801,698,047 0.7%   
Gross profit Rs m3,247465,011 0.7%  
Depreciation Rs m281137,255 0.2%   
Interest Rs m833,352 0.0%   
Profit before tax Rs m3,142294,404 1.1%   
Minority Interest Rs m01,337 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,260 -0.0%   
Tax Rs m847-3,594 -23.6%   
Profit after tax Rs m2,295106,076 2.2%  
Gross profit margin %26.427.4 96.4%  
Effective tax rate %27.0-1.2 -2,208.8%   
Net profit margin %18.76.2 298.7%  
BALANCE SHEET DATA
Current assets Rs m11,7131,146,855 1.0%   
Current liabilities Rs m6,7911,000,154 0.7%   
Net working cap to sales %40.08.6 463.3%  
Current ratio x1.71.1 150.4%  
Inventory Days Days26391 289.4%  
Debtors Days Days34396 358.1%  
Net fixed assets Rs m10,617554,620 1.9%   
Share capital Rs m1664,180 4.0%   
"Free" reserves Rs m7,2650-   
Net worth Rs m7,4311,886,208 0.4%   
Long term debt Rs m0868,249 0.0%   
Total assets Rs m22,3303,880,582 0.6%  
Interest coverage x409.19.8 4,162.5%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 125.8%   
Return on assets %10.33.6 287.0%  
Return on equity %30.95.6 549.1%  
Return on capital %42.44.9 859.6%  
Exports to sales %00-   
Imports to sales %13.10-   
Net fx Rs m-1400-   
CASH FLOW
From Operations Rs m2,360270,581 0.9%  
From Investments Rs m-215-95,878 0.2%  
From Financial Activity Rs m-985-324,580 0.3%  
Net Cashflow Rs m1,160-149,877 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.59 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare PROCTER & GAMBLE HEALTH With: EVEREST ORGANICS  BAJAJ HEALTHCARE  VIVIMED LABS  CIPLA  ISHITA DRUGS  



Today's Market

Sensex Today Trades Lower | Nifty Below 22,150 | Vodafone Idea Falls 3%, TCS 2% Sensex Today Trades Lower | Nifty Below 22,150 | Vodafone Idea Falls 3%, TCS 2%(10:30 am)

Asian markets extended decline and traded lower on Tuesday ahead of key economic data from China and as geopolitical tension intensified in the Middle East.